International classification of retinopathy of prematurity
Purpose The International Classification of Retinopathy of Prematurity is a consensus
statement that creates a standard nomenclature for classification of retinopathy of …
statement that creates a standard nomenclature for classification of retinopathy of …
VEGF in signaling and disease: beyond discovery and development
The discovery of vascular endothelial-derived growth factor (VEGF) has revolutionized our
understanding of vasculogenesis and angiogenesis during development and physiological …
understanding of vasculogenesis and angiogenesis during development and physiological …
Ranibizumab versus laser therapy for the treatment of very low birthweight infants with retinopathy of prematurity (RAINBOW): an open-label randomised controlled …
A Stahl, D Lepore, A Fielder, B Fleck, JD Reynolds… - The Lancet, 2019 - thelancet.com
Background Despite increasing worldwide use of anti-vascular endothelial growth factor
agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular …
agents for treatment of retinopathy of prematurity (ROP), there are few data on their ocular …
Automated diagnosis of plus disease in retinopathy of prematurity using deep convolutional neural networks
Importance Retinopathy of prematurity (ROP) is a leading cause of childhood blindness
worldwide. The decision to treat is primarily based on the presence of plus disease, defined …
worldwide. The decision to treat is primarily based on the presence of plus disease, defined …
Molecular mechanism of VEGF and its role in pathological angiogenesis
Over the last seven decades, a significant scientific contribution took place in the delineation
of the implications of vascular endothelial‐derived growth factor (VEGF) in the processes of …
of the implications of vascular endothelial‐derived growth factor (VEGF) in the processes of …
Effect of intravitreal aflibercept vs laser photocoagulation on treatment success of retinopathy of prematurity: the FIREFLEYE randomized clinical trial
A Stahl, EA Sukgen, WC Wu, D Lepore, H Nakanishi… - Jama, 2022 - jamanetwork.com
Importance Laser photocoagulation, which is the standard treatment for retinopathy of
prematurity (ROP), can have adverse events. Studies of anti–vascular endothelial growth …
prematurity (ROP), can have adverse events. Studies of anti–vascular endothelial growth …
Retinal vasculature development in health and disease
S Selvam, T Kumar, M Fruttiger - Progress in retinal and eye research, 2018 - Elsevier
Abstract Development of the retinal vasculature is based on highly coordinated signalling
between different cell types of the retina, integrating internal metabolic requirements with …
between different cell types of the retina, integrating internal metabolic requirements with …
Short-and long-term outcomes for extremely preterm infants
RM Patel - American journal of perinatology, 2016 - thieme-connect.com
Prematurity is the leading cause of infant mortality worldwide. In developed countries,
extremely preterm infants contribute disproportionately to both neonatal and infant mortality …
extremely preterm infants contribute disproportionately to both neonatal and infant mortality …
Mechanisms and management of retinopathy of prematurity
ME Hartnett, JS Penn - New England Journal of Medicine, 2012 - Mass Medical Soc
Mechanisms and Management of Retinopathy of Prematurity | New England Journal of Medicine
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Skip to main content The New England Journal of Medicine homepage Advanced Search …
Anti‐vascular endothelial growth factor (VEGF) drugs for treatment of retinopathy of prematurity
Background Vascular endothelial growth factor (VEGF) plays a key role in angiogenesis in
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …
foetal life. Researchers have recently attempted to use anti‐VEGF agents for the treatment of …